A real-world study in Spain finds faster improvements with induction therapy but highlights long-term drug survival ...
The US Food and Drug Administration (FDA) has approved Sanofi’s Merilog (insulin-aspart-szjj), a biosimilar to Novolog ...
Merilog’s approval comes as the insulin space has over the past year suffered several setbacks, including strong calls for ...
We recently published a list of the 10 Best Drug Stocks to Buy Now. In this article, we are going to take a look at where Eli ...
WashU Medicine-led trial evaluating investigational drug from Eli Lilly and Company aims to stop disease before symptoms ...
5d
Hosted on MSNLLY Rises More Than 4% in a Week: How to Play the StockEli Lilly and Company’s LLY shares have risen 4.3% since it reported fourth-quarter results on Feb. 6. Lilly’s fourth-quarter ...
Eli Lilly continues to see strong growth coming from its GLP-1 drugs. The company's current 2025 guidance looks conservative.
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results